Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) CEO Roger Crystal spoke with Proactive Investors at the BIO CEO & Investor Conference in New York. Read More
The post Opiant Pharmaceuticals, developer of NARCAN, looks to prevent cannabinoid overdose appeared first on Dagga Magazine.